Biotechnology Companies By Cash Per Share

Cash Per Share
Cash Per ShareEfficiencyMarket RiskExp Return
1GLPG Galapagos NV ADR
67.38
(0.08)
 1.72 
(0.13)
2REGN Regeneron Pharmaceuticals
65.75
 0.25 
 1.11 
 0.27 
3BGNE BeiGene
55.17
(0.03)
 3.30 
(0.10)
4UTHR United Therapeutics
49.55
(0.05)
 1.63 
(0.09)
5IMAB I Mab
47.2
 0.07 
 6.27 
 0.44 
6ARGX Argenx NV ADR
47.17
(0.06)
 3.86 
(0.23)
7BNTX BioNTech SE
38.3
(0.08)
 2.18 
(0.17)
8VRTX Vertex Pharmaceuticals
38.06
 0.16 
 2.03 
 0.32 
9BIIB Biogen Inc
34.1
(0.05)
 1.70 
(0.08)
10GMAB Genmab AS
33.05
(0.11)
 2.10 
(0.23)
11CRSP Crispr Therapeutics AG
26.48
 0.09 
 4.06 
 0.38 
12THRD Third Harmonic Bio
25.53
 0.05 
 3.81 
 0.18 
13SAGE Sage Therapeutic
25.47
 0.03 
 3.91 
 0.13 
14GRCL Gracell Biotechnologies
25.28
 0.17 
 8.31 
 1.45 
15SRPT Sarepta Therapeutics
23.61
 0.22 
 3.26 
 0.71 
16CNTB Connect Biopharma Holdings
23.26
 0.07 
 7.58 
 0.56 
17ITOS Iteos TherapeuticsInc
22.26
 0.05 
 3.37 
 0.15 
18MRNA Moderna
21.73
 0.08 
 3.94 
 0.31 
19AMGN Amgen Inc
21.51
 0.02 
 1.39 
 0.03 
20ALNY Alnylam Pharmaceuticals
18.41
(0.05)
 2.61 
(0.14)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it. Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.